Trial Profile
Comparative study between the usage of corifollitropin alfa and daily recombinant FSH in the ovarian stimulation of low responders
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Corifollitropin alfa (Primary) ; Follicle stimulating hormones; Follicle stimulating hormones; Menotropin
- Indications Female infertility
- Focus Therapeutic Use
- 15 Jan 2016 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 24 Aug 2015 Planned End Date changed from 1 Dec 2015 to 1 Jan 2016, as reported by ClinicalTrials.gov.
- 24 Aug 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Jan 2016, as reported by ClinicalTrials.gov.